Liver Insights: Probing Molecular Signatures of Hepatitis C Patients in Hospitals of Lahore- Navigating the Clinical Landscape of Viral Infection and Organ Profiling
DOI:
https://doi.org/10.61919/jhrr.v4i1.565Keywords:
Hepatitis C, Prevalence, Gender Disparity, Viral Load Detection, Hospitalization Duration, Cross-Sectional Study, Pakistan, Hepatology, Public Health, EpidemiologyAbstract
Background: Hepatitis C virus (HCV) infection is a major public health problem, leading to chronic liver diseases, cirrhosis, and hepatocellular carcinoma. The disease burden is particularly high in developing countries, with significant gender disparities and varied outcomes across different clinical settings.
Objective: The study aimed to assess the prevalence of HCV infections, analyze the clinical correlation of demographic factors with patient outcomes, and examine the age-related duration of hospital stays in a Pakistani cohort.
Methods: A cross-sectional retrospective study was conducted on 230 symptomatic liver patients from three major hospitals in Lahore. Inclusion criteria were based on HCV-related liver conditions, excluding post-liver transplant patients. Data on viral load detections were obtained via semi-automated RT-PCR with commercially available kits. Statistical analysis was performed using SPSS version 25 and GraphPad Prism 9.0 to determine frequency distributions, cross-tabulation analyses, and Pearson correlation coefficients.
Results: Out of the 230 patients, 69% (158) were male, and 31% (72) were female. Age distribution showed 36.7% (58) of males were over 60 years, and 63.3% (100) under 60 years; 55.6% (40) of females were over 45 years, with 44.4% (32) under 45 years. Most referrals came from the Pulmonary ward (35%), followed by the Surgery (30%) and Gastroenterology (20%) wards. HCV RNA detection was positive in 67% (154) of the patients. Cross-tabulation analysis indicated a mortality rate of 39% in the Pulmonary ward. A significant positive correlation (r=0.494, p<0.000) was observed between patient age and days of hospital stay.
Conclusion: The study demonstrates a higher prevalence of HCV in males and a notable age-related impact on the duration of hospitalization. Interdisciplinary approaches and gender-sensitive healthcare interventions are essential for effective HCV management.
Downloads
References
Ball LE, Agana B, Comte‐Walters S, Rockey DC, Masur H, Kottilil S, et al. Hepatitis C virus treatment with direct‐acting antivirals induces rapid changes in the hepatic proteome. Journal of Viral Hepatitis. 2021;28(11):1614-23.
Butterworth J, Gregoire D, Peter M, Roca Suarez A, Desandré G, Simonin Y, et al. Zine El Aabidine, A.; Guivarch, M.; Flandrau, J.-C.; et al. GOLT1B Activation in Hepatitis C Virus-Infected Hepatocytes Links ER Trafficking and Viral Replication. Pathogens 2022, 11, 46. s Note: MDPI stays neutral with regard to jurisdictional claims in published …; 2021.
Che Z, Zhou Z, Li S-Q, Gao L, Xiao J, Wong N-K. ROS/RNS as molecular signatures of chronic liver diseases. Trends in molecular medicine. 2023.
Dalzell CG, Taylor AC, White SB. New Insights on Liver-Directed Therapies in Hepatocellular Carcinoma. Cancers. 2023;15(24):5749.
Farhan M, Fazal F, Dave T, Butt A, Basit J, Maqbool S. National hepatitis registry in Pakistan: a dire need for hepatitis surveillance and control. Tropical Medicine and Health. 2023;51(1):41.
Franco S, Buccione D, Tural C, Martinez MA. Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/hepatitis C virus coinfections. Aids. 2021;35(9):1355-63.
Fujiwara N, Kubota N, Crouchet E, Koneru B, Marquez CA, Jajoriya AK, et al. Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease. Science translational medicine. 2022;14(650):eabo4474.
Hsu MH. Identification and Validation of a Common Molecular Signature of Progressive Fibrosis in Human Livers. 2020.
Huang CH, Fan JH, Jeng WJ, Chang ST, Yang CK, Teng W, et al. Innate‐like bystander‐activated CD38+ HLA‐DR+ CD8+ T cells play a pathogenic role in patients with chronic hepatitis C. Hepatology. 2022;76(3):803-18.
Li H, Huang M-H, Jiang J-D, Peng Z-G. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy. World journal of gastroenterology. 2018;24(47):5297.
Lim HK, Jeffrey GP, Ramm GA, Soekmadji C. Pathogenesis of viral hepatitis-induced chronic liver disease: role of extracellular vesicles. Frontiers in Cellular and Infection Microbiology. 2020;10:587628.
Lindqvist K, Thorin Z, Kåberg M. Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden. Harm Reduction Journal. 2023;20(1):1-11.
Moorman AC, Rupp LB, Gordon SC, Zhong Y, Xing J, Lu M, et al. Long-term liver disease, treatment, and mortality outcomes among 17,000 persons diagnosed with chronic hepatitis C virus infection: current chronic hepatitis cohort study status and review of findings. Infectious Disease Clinics. 2018;32(2):253-68.
Nasir S, Majeed MI, Nawaz H, Rashid N, Ali S, Farooq S, et al. Surface enhanced Raman spectroscopy of RNA samples extracted from blood of hepatitis C patients for quantification of viral loads. Photodiagnosis and Photodynamic Therapy. 2021;33:102152.
Nosaka T, Naito T, Matsuda H, Ohtani M, Hiramatsu K, Nemoto T, et al. Molecular signature of hepatitis B virus regulation by interferon‐γ in primary human hepatocytes. Hepatology Research. 2020;50(3):292-302.
Pimenov N, Kostyushev D, Komarova S, Fomicheva A, Urtikov A, Belaia O, et al. Epidemiology and Genotype Distribution of Hepatitis C Virus in Russia. Pathogens. 2022;11(12):1482.
Shanmuganathan M, Sarfaraz MO, Kroezen Z, Philbrick H, Poon R, Don-Wauchope A, et al. A cross-platform metabolomics comparison identifies serum metabolite signatures of liver fibrosis progression in chronic hepatitis c patients. Frontiers in Molecular Biosciences. 2021;8:676349.
Rafiq S, Majeed MI, Nawaz H, Rashid N, Yaqoob U, Batool F, et al. Surface-enhanced Raman spectroscopy for analysis of PCR products of viral RNA of hepatitis C patients. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2021;259:119908.
Shafat Z, Farooqui A, Tamkeen N, Islam A, Chaudhary AA, Alawam AS, et al. Identification of Stage-Specific Differentially Expressed Genes and Network Meta-Analysis Reveals Potential Molecular Signatures in Chronic Hepatitis E Virus Infection. 2023.
Poma AM, Basolo A, Bonuccelli D, Proietti A, Macerola E, Ugolini C, et al. Activation of type I and type II interferon signaling in SARS-CoV-2-positive thyroid tissue of patients dying from COVID-19. Thyroid. 2021;31(12):1766-75.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Amna Batool, Asra Shujayat, Maryum Sana, Aqsa Yasin
This work is licensed under a Creative Commons Attribution 4.0 International License.
Public Licensing Terms
This work is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this license:
- You are free to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, including commercial use.
- Attribution must be given to the original author(s) and source in a manner that is reasonable and does not imply endorsement.
- No additional restrictions may be applied that conflict with the terms of this license.
For more details, visit: https://creativecommons.org/licenses/by/4.0/.
